{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:55:50Z","timestamp":1790049350842,"version":"4.0.1"},"reference-count":41,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T00:00:00Z","timestamp":1483488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Stomach infection with Helicobacter pylori (H. pylori) causes severe gastroduodenal diseases in a large number of patients worldwide. The H. pylori infection breaks up in early childhood, persists lifelong if not treated, and is associated with chronic gastritis and an increased risk of peptic ulcers and gastric cancer. In recent years, the problem of drug-resistant strains has become a global concern that makes the treatment more complicated and the infection persistent at higher levels when the antibiotic treatment is stopped. Such problems have led to the development of new strategies to eradicate an H. pylori infection. Currently, one of the most important strategies for the treatment of H. pylori infection is the use of urease inhibitors. Despite the fact that large numbers of molecules have been shown to exert potent inhibitory activity against H. pylori urease, most of them were prevented from being used in vivo and in clinical trials due to their hydrolytic instability, toxicity, and appearance of undesirable side effects. Therefore, it is crucial to focus attention on the available opportunities for the development of urease inhibitors with suitable pharmacokinetics, high hydrolytic stability, and free toxicological profiles. In this commentary, we aim to afford an outline on the current status of the use of urease inhibitors in the treatment of an H. pylori infection, and to discuss the possibility of their development as effective drugs in clinical trials.<\/jats:p>","DOI":"10.3390\/children4010002","type":"journal-article","created":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T09:39:32Z","timestamp":1483522772000},"page":"2","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The Development of Urease Inhibitors: What Opportunities Exist for Better Treatment of Helicobacter pylori Infection in Children?"],"prefix":"10.3390","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3922-2738","authenticated-orcid":false,"given":"Sherif","family":"Hassan","sequence":"first","affiliation":[{"name":"Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palack\u00e9ho t\u0159. 1946\/1, 61242 Brno, Czech Republic"},{"name":"Department of Applied Ecology, Faculty of Environmental Sciences, Czech University of Life Sciences Prague, Kam\u00fdck\u00e1 129, 165 21 Praha 6\u2014Suchdol, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslava","family":"\u0160udomov\u00e1","sequence":"additional","affiliation":[{"name":"Museum of the Brno Region, Museum of Literature in Moravia, Porta Coeli 1001, 66602 P\u0159edkl\u00e1\u0161te\u0159\u00ed, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,1,4]]},"reference":[{"key":"ref_1","first-page":"2324","article-title":"Sequential therapy versus standard triple therapy in Helicobacter pylori eradication in a high clarithromycin resistance setting","volume":"7","author":"Dolapcioglu","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1046\/j.1365-2036.2002.0160s1003.x","article-title":"Review article: Natural history and epidemiology of Helicobacter pylori infection","volume":"16","author":"Go","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.mrfmmm.2009.02.002","article-title":"Interaction between Helicobacter pylori, diet, and genetic polymorphisms as related to non-cancer diseases","volume":"667","author":"Izzotti","year":"2009","journal-title":"Mutat. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1590\/S0004-28032008000200011","article-title":"Decrease in prevalence of Helicobacter pylori infection during a 10-year period in Brazilian children","volume":"45","author":"Kawakami","year":"2008","journal-title":"Arq. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00054-05","article-title":"Pathogenesis of Helicobacter pylori infection","volume":"19","author":"Kusters","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11938-014-0027-6","article-title":"Current Paradigm and Future Directions for Treatment of Helicobacter pylori Infection","volume":"12","author":"Ferreira","year":"2014","journal-title":"Curr. Treat. Options Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1523-5378.2009.00671.x","article-title":"Meta-analysis: Four-drug, three-antibiotic, non-bismuth-containing \u201cconcomitant therapy\u201d versus triple therapy for Helicobacter pylori eradication","volume":"14","author":"Essa","year":"2009","journal-title":"Helicobacter"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.36290\/csf.2015.058","article-title":"Antibacterial activity of natural compounds\u2014essential oils","volume":"64","author":"Hassan","year":"2015","journal-title":"Ceska Slov. Farm."},{"key":"ref_9","first-page":"81","article-title":"From Prout to the proton pump\u2014A history of the science of gastric acid secretion and the surgery of peptic ulcer","volume":"170","author":"Modlin","year":"1990","journal-title":"Surg. Gynecol. Obstet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jgar.2015.09.009","article-title":"Antimicrobial susceptibility profiles of Helicobacter pylori isolated from patients in North India","volume":"5","author":"Gehlot","year":"2016","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12664-015-0535-x","article-title":"Ciprofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: A randomized trial","volume":"34","author":"Chaabane","year":"2015","journal-title":"Indian J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bmj.320.7226.31","article-title":"Regular review: Treatment of Helicobacter pylori infection","volume":"320","author":"Guido","year":"2000","journal-title":"Br. Med. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.7314\/APJCP.2015.16.4.1571","article-title":"Does treatment of Helicobacter pylori infection reduce gastric precancerous lesions?","volume":"16","author":"Joukar","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1523-5378.2000.00013.x","article-title":"Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy","volume":"5","author":"Nagahara","year":"2000","journal-title":"Helicobacter"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.20452\/pamw.440","article-title":"Clinical aspects of Helicobacter pylori infection","volume":"118","author":"Bartnik","year":"2008","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/hel.12163","article-title":"Treatment of Helicobacter pylori infection 2014","volume":"19","author":"Vaira","year":"2014","journal-title":"Helicobacter"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3109\/13880209.2015.1126618","article-title":"In vitro synergistic effect of Hibiscus sabdariffa aqueous extract in combination with standard antibiotics against Helicobacter pylori clinical isolates","volume":"54","author":"Hassan","year":"2016","journal-title":"Pharm. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0969-2126(99)80026-4","article-title":"A new proposal for urease mechanism based on the crystal structures of the native and inhibited enzyme from Bacillus pasteurii: Why urea hydrolysis costs two nickels","volume":"7","author":"Benini","year":"1999","journal-title":"Structure"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/ja049618p","article-title":"Molecular details of urease inhibition by boric acid: insights into the catalytic mechanism","volume":"126","author":"Benini","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1517\/13543776.2011.574615","article-title":"Urease inhibitors as potential drugs for gastric and urinary tract infections: A patent review","volume":"21","author":"Kosikowska","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Adu-Aryee, N.A., Aabakken, L., Dedey, F., Nsaful, J., and Kudzi, W. (2016). Comparison of endoscopic based diagnosis with Helicobacter urease test for Helicobacter pylori infection. BMC Res. Notes, 9.","DOI":"10.1186\/s13104-016-2237-6"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1021\/acs.jmedchem.6b00986","article-title":"1,2-Benzisoselenazol-3(2H)-one Derivatives As a New Class of Bacterial Urease Inhibitors","volume":"59","author":"Macegoniuk","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0966-842X(01)02287-9","article-title":"Acid survival of Helicobacter pylori: How does urease activity trigger cytoplasmic pH homeostasis?","volume":"10","author":"Stingl","year":"2002","journal-title":"Trends Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1126\/science.287.5452.482","article-title":"A H+-gated urea channel: The link between Helicobacter pylori urease and gastric colonization","volume":"287","author":"Weeks","year":"2000","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/IAI.66.11.5060-5066.1998","article-title":"Helicobacter pylori containing only cytoplasmic urease is susceptible to acid","volume":"66","author":"Krishnamurthy","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0882-4010(91)90062-F","article-title":"Characterization of the Helicobacter pylori urease and purification of its subunits","volume":"10","author":"Evans","year":"1991","journal-title":"Microb. Pathog."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/88563","article-title":"Supramolecular assembly and acid resistance of Helicobacter pylori urease","volume":"8","author":"Ha","year":"2001","journal-title":"Nat. Struct. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12038-009-0069-4","article-title":"Helicobacter urease: Niche construction at the single molecule level","volume":"34","author":"Khan","year":"2009","journal-title":"J. Biosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1128\/jb.177.8.1947-1951.1995","article-title":"Evidence for the presence of urease apoprotein complexes containing UreD, UreF, and UreG in cells that are competent for in vivo enzyme activation","volume":"177","author":"Park","year":"1995","journal-title":"J. Bacteriol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1128\/iai.60.7.2657-2666.1992","article-title":"Purification of recombinant Helicobacter pylori urease apoenzyme encoded by ureA and ureB","volume":"60","author":"Hu","year":"1992","journal-title":"Infect. Immun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0045-2068(91)90048-T","article-title":"Recent advances in the chemistry of an old enzyme, urease","volume":"19","author":"Zerner","year":"1991","journal-title":"Bioorg. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1365-2958.2000.01835.x","article-title":"Acid resistance of Helicobacter pylori depends on the UreI membrane protein and an inner membrane proton barrier","volume":"36","author":"Rektorschek","year":"2000","journal-title":"Mol. Microb."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/IAI.68.2.470-477.2000","article-title":"Expression of the Helicobacter pylori ureI gene is required for acidic pH activation of cytoplasmic urease","volume":"68","author":"Scott","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ardp.201500019","article-title":"Plant-Derived Urease Inhibitors as Alternative Chemotherapeutic Agents","volume":"349","author":"Hassan","year":"2016","journal-title":"Arch. Pharm. (Weinh.)"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.arcmed.2014.09.001","article-title":"In vitro assessment of Helicobacter pylori ureases inhibition by honey fractions","volume":"45","author":"Matongo","year":"2014","journal-title":"Arch. Med. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4103\/1735-5362.189319","article-title":"Synthesis and evaluation of the complex-forming ability of hydroxypyranones and hydroxypyridinones with Ni (II) as possible inhibitors for urease enzyme in Helicobacter pylori","volume":"11","author":"Palizban","year":"2016","journal-title":"Res. Pharm. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jare.2014.09.001","article-title":"An overview on the potential of natural products as ureases inhibitors: A review","volume":"6","author":"Modolo","year":"2015","journal-title":"J. Adv. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jcp.2009.072595","article-title":"Ureases as a target for the treatment of gastric and urinary infections","volume":"63","author":"Follmer","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1208\/s12249-015-0443-5","article-title":"Lectin-Conjugated Clarithromycin and Acetohydroxamic Acid-Loaded PLGA Nanoparticles: A Novel Approach for Effective Treatment of H. pylori","volume":"17","author":"Jain","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2004.06.006","article-title":"Receptor-mediated targeting of lipobeads bearing acetohydroxamic acid for eradication of Helicobacter pylori","volume":"99","author":"Umamaheshwari","year":"2004","journal-title":"J. Control. Release"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00257208","article-title":"Urease stones","volume":"7","author":"Griffith","year":"1979","journal-title":"Urol. Res."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/4\/1\/2\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:25:26Z","timestamp":1760207126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/4\/1\/2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1]]}},"alternative-id":["children4010002"],"URL":"https:\/\/doi.org\/10.3390\/children4010002","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,4]]}}}